Pharmacology of Drugs of Abuse During Pregnancy
怀孕期间滥用药物的药理学
基本信息
- 批准号:10463599
- 负责人:
- 金额:$ 147.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:18 year oldAddressAdolescenceAffectAmericanAnimalsBrainCNR1 geneCannabinoidsCannabisCellsChildClinical TrialsConsensusConsumptionControlled Clinical TrialsDataDevelopmentDiscipline of obstetricsDoseDrug KineticsDrug TransportEthicsExposure toFetal LiverFetusFrequenciesFundingFutureGestational AgeGlucuronidesGoalsGynecologyHumanImpairmentIn VitroInfantInfectionInhalationKnowledgeLinkMarijuanaMaternal ExposureMental disordersMeta-AnalysisMetabolicMetabolismMethodsModelingMolecular ProfilingMorbidity - disease rateMusNeurologicNeuronsOdds RatioOrganOutcomePharmaceutical PreparationsPharmacologyPlacentaPlasmaPregnancyPregnant WomenPrevalenceProteomicsPublic HealthRaceRecommendationRiskRodentSchizophreniaSchoolsSignal TransductionSystemTHC concentrationTHC exposureTestingTetrahydrocannabinolTissuesTobaccoToxic effectUnited States National Institutes of HealthVisual attentionadverse outcomeage relatedanimal dataaxon growthclinically relevantcollegedesigndevelopmental neurotoxicitydrug dispositiondrug of abusefetalfetal marijuana exposurehuman dataillicit drug usein vivoinnovationmarijuana usemarijuana use in pregnancymaternal marijuana usemetabolomemetabolomicsmodel developmentmodels and simulationneonatal deathneonatal morbidityneonatal outcomenovelperpetratorsphysiologically based pharmacokineticsplacental transferpregnantprenatalprenatal exposureprogramsstatisticstoolunethicalvisual memory
项目摘要
Use of marijuana (cannabis) among pregnant women in the US is increasing with prevalence as high as
14% among 12–18 year old pregnant women. The American College of Obstetrics
and Gynecology recommends that pregnant women avoid marijuana due to evidence that it affects
the fetus and may interfere with brain development. Studies in animals appear to support this
recommendation. Although other constituents of marijuana cannot be discounted, the general scientific
consensus is that ∆9-tetrahydrocannabinol (THC), the most abundant and psychoactive component in
marijuana, is the likely perpetrator of the developmental neurotoxicity of marijuana. However, these animal
and in vitro studies were conducted at high THC doses or concentrations and therefore their applicability to
humans, where THC plasma concentrations are sub-micromolar, is unknown. On the other hand, human data
on fetal and infant developmental outcomes due to marijuana use during pregnancy are limited, confounded by
other factors and remain controversial. Conducting a controlled clinical trial to determine if marijuana results in
negative fetal/neonatal outcomes is unethical. Therefore, alternative approaches to determine fetal outcomes
of marijuana use during pregnancy need to be explored. However, this can only be achieved when the fetal
exposure to THC and its active metabolite,11-OH-THC, has been addressed and accurately predicted. To
achieve this goal, we propose a systems pharmacology approach to begin to address this significant public
health problem and test the central hypothesis: Maternal-fetal exposure for THC/11-OH-THC during
pregnancy can be predicted through innovative in vitro and in vivo studies integrated through
maternal-fetal PBPK modeling and simulation (m-f-PBPK M & S). Fetal exposure to THC/11-OH-THC will
be dependent on their maternal disposition, placental transport/metabolism and fetal clearance. Fetal exposure
to THC/11-OH-THC will drive their fetal toxicity. Therefore, the projects of this P01 are designed to: 1)
understand fetal exposure to THC/11-OH-THC by characterizing metabolism and transport of THC/11-OH-THC
in maternal organs, placenta and fetus (Project 1); 2) predict the changes in maternal exposure to THC and its
comprehensive metabolome including 11-OH-THC, 11-nor-COOH-THC and the glucuronides, throughout
pregnancy, and the mechanistic basis for these changes (Project 2); and 3) predict and verify gestational age-
dependent placental-fetal exposure to THC/11-OH-THC through PBPK M & S by integrating the data from the
above two projects (Project 3). In addition, in an exploratory manner, we will determine whether these
cannabinoids produce any molecular signatures indicative of short or long-term developmental neurotoxicity in
humans (Project 3). Our approach uses novel and innovative tools (e.g. m-f-PBPK model, development of an
inhalational m-f-PBPK model, perfused human placenta, quantitative targeted proteomics and metabolomics)
to address a compelling public health question.
在美国,孕妇使用大麻(大麻)的比例越来越高,
12-18岁孕妇中为14%。美国产科学院
妇科建议孕妇避免大麻,因为有证据表明,它会影响
胎儿,可能会干扰大脑发育。对动物的研究似乎支持这一点
推荐虽然大麻的其他成分不能被忽视,但一般的科学研究表明,
共识是,大麻中最丰富的精神活性成分-
大麻,是大麻发育神经毒性的可能肇事者。然而,这些动物
体外研究是在高THC剂量或浓度下进行的,因此它们适用于
人类,其中THC血浆浓度是亚微摩尔,是未知的。另一方面,人类数据
由于怀孕期间使用大麻对胎儿和婴儿发育结果的影响有限,
其他因素,仍有争议。进行对照临床试验,以确定大麻是否会导致
胎儿/新生儿的阴性结果是不道德的。因此,确定胎儿结局的替代方法
在怀孕期间使用大麻需要探索。然而,这只能在胎儿
暴露于THC及其活性代谢物11-OH-THC的风险已经得到解决和准确预测。到
实现这一目标,我们提出了一个系统药理学的方法,开始,以解决这一重大公众
健康问题和测试中心假设:母亲-胎儿接触THC/11-OH-THC期间
怀孕可以通过创新的体外和体内研究预测,
母胎PBPK建模和模拟(m-f-PBPK M & S)。胎儿暴露于THC/11-OH-THC将
取决于母体倾向、胎盘转运/代谢和胎儿清除率。胎儿暴露
THC/11-OH-THC会导致胎儿毒性。因此,本P01项目设计为:1)
通过表征THC/11-OH-THC的代谢和转运,了解胎儿暴露于THC/11-OH-THC
(2)预测母亲暴露于THC的变化及其对THC的影响(项目1)
全面的代谢物组,包括11-OH-THC,11-nor-COOH-THC和葡萄糖醛酸,贯穿始终
妊娠,以及这些变化的机制基础(项目2);和3)预测和验证胎龄-
通过PBPK M & S,通过整合来自
以上两个项目(项目3)。此外,我们将以探索性的方式确定这些
大麻素产生任何指示短期或长期发育神经毒性的分子特征,
人类(项目3)。我们的方法使用新颖和创新的工具(例如,m-f-PBPK模型,
吸入m-f-PBPK模型,灌注人胎盘,定量靶向蛋白质组学和代谢组学)
来解决一个紧迫的公共卫生问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASHVANT D Unadkat其他文献
JASHVANT D Unadkat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASHVANT D Unadkat', 18)}}的其他基金
Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain
人胎盘、肠道和胎儿大脑发育中转运蛋白的鉴定、定量和功能表征
- 批准号:
10746192 - 财政年份:2023
- 资助金额:
$ 147.51万 - 项目类别:
PBPK prediction and verification of maternal-fetal exposure to cannabinoids
母胎大麻素暴露的 PBPK 预测和验证
- 批准号:
10688214 - 财政年份:2013
- 资助金额:
$ 147.51万 - 项目类别:
PBPK prediction and verification of maternal-fetal exposure to cannabinoids
母胎大麻素暴露的 PBPK 预测和验证
- 批准号:
10231037 - 财政年份:2013
- 资助金额:
$ 147.51万 - 项目类别:
Pharmacology of Drugs of Abuse During Pregnancy
怀孕期间滥用药物的药理学
- 批准号:
10688212 - 财政年份:2013
- 资助金额:
$ 147.51万 - 项目类别:
Pharmacology of Drugs of Abuse During Pregnancy
怀孕期间滥用药物的药理学
- 批准号:
10231036 - 财政年份:2013
- 资助金额:
$ 147.51万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 147.51万 - 项目类别:
Research Grant